Lymph node surgery in papillary thyroid carcinoma

被引:105
|
作者
Gemsenjäger, E [1 ]
Perren, A
Seifert, B
Schüler, G
Schweizer, I
Heitz, PU
机构
[1] Spital Zollikerberg, Surg Clin, CH-8125 Zurich, Switzerland
[2] Univ Zurich, Dept Pathol, CH-8006 Zurich, Switzerland
[3] Univ Zurich, Dept Biostat, CH-8006 Zurich, Switzerland
关键词
D O I
10.1016/S1072-7515(03)00421-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: The impact of nodal disease remains controversial in papillary thyroid carcinoma (PTC). STUDY DESIGN: One surgeon treated 159 unselected patients, who were followed up for 1 to 27 years. We present a retrospective analysis with respect to nodal disease. Occult nodal disease was investigated, including metachronous nodal disease (mpN(I)) in primarily node negative patients (pN(0), clinical [c]N-0). RESULTS: Therapeutic lymphadenectomies, prophylactic lymphadenectomies, or no lymphadenectomy were carried out in 42 (cN(1)), 29 (cN(0)), and 88 (cN(0)) patients, respectively, with stage pN(1) in 41 (98%), in 5 (17%), and in 2 (2.3%) patients, respectively (17% versus 2.3% p < 0.005). Sensitivity and specificity of clinical staging were 85% and 99%, respectively. More frequent prophylactic lymphadenectomy during the study period (p = 0.002) led to a nonsignificant increase in stage pN(1) (26% versus 30%). Immunohistochemistry led to upstaging of only 3% of histologically negative nodes and one (4%) pN(0) patient. Nodal recurrence occurred in 8 of 156 patients (5%) treated for cure, in 12% of pN(1) versus 3% of pN(0) cN(0) tumors (p = 0.009), in 15% of TNM high-versus 3% of low-risk patients (p = 0.006), and in 5% each of patients, younger than 45 and 45 years or more. In TNM high-risk patients, tumor-related survival was 50% for stage pN(1) versus 86% for stage pN(0), cN(0) (p = 0.03) (100% and 100% in low-risk patients). CONCLUSIONS: The rate of occult nodal disease might be relatively low, and it does not frequently progress to clinical recurrent disease. Clinical nodal status might be valid for deciding the extent and radicality of node dissection. Prophylactic (central) lymphadenectomy should be carried out without radicality-associated morbidity. Macroscopic nodal disease warrants more rigorous, compartment-oriented lymphadenectomy. There is no rationale for detection of occult disease and micrometastasis by frozen section or immunohistochemistry. (C) 2003 by the American College of Surgeons.
引用
收藏
页码:182 / 190
页数:9
相关论文
共 50 条
  • [1] Lymph Node Surgery in Papillary Thyroid Carcinoma
    Karakoc, Derya
    Ozdemir, Arif
    INTERNATIONAL SURGERY, 2010, 95 (02) : 142 - 146
  • [2] Lymph Node Dissection in Papillary Thyroid Carcinoma
    Moo, Tracy-Ann S.
    Fahey, Thomas J., III
    SEMINARS IN NUCLEAR MEDICINE, 2011, 41 (02) : 84 - 88
  • [3] Papillary thyroid carcinoma with lymph node metastases
    Lin, Jen-Der
    GROWTH FACTORS, 2007, 25 (01) : 41 - 49
  • [4] Prophylactic Lymph Node Dissection in Papillary Thyroid Carcinoma
    Jeong, Han-Sin
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (11) : 3324 - 3325
  • [5] Cystic lymph node metastasis in papillary thyroid carcinoma
    Miseikyte-Kaubriene, Edita
    Trakymas, Mantas
    Ulys, Albertas
    MEDICINA-LITHUANIA, 2008, 44 (06): : 455 - 459
  • [6] Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
    Ashok R. Shaha
    World Journal of Surgery, 2018, 42 : 630 - 631
  • [7] Sentinel lymph node dissection in papillary thyroid carcinoma
    Chow, TL
    Lim, BH
    Kwok, SPY
    ANZ JOURNAL OF SURGERY, 2004, 74 (1-2) : 10 - 12
  • [8] Lymph node dissection in papillary or follicular thyroid carcinoma
    Bononi, M
    Tocchi, A
    Cangemi, V
    Vecchione, A
    Giovagnoli, MR
    De Cesare, A
    Fiori, E
    Volpino, P
    Brozzetti, S
    Meucci, M
    Scozzafava, S
    Cavallaro, A
    ANTICANCER RESEARCH, 2004, 24 (04) : 2439 - 2442
  • [9] Prophylactic Lymph Node Dissection in Papillary Thyroid Carcinoma
    Antonio Toniato
    Annals of Surgical Oncology, 2008, 15 : 3322 - 3323
  • [10] Prophylactic Lymph Node Dissection in Papillary Thyroid Carcinoma
    Han-Sin Jeong
    Annals of Surgical Oncology, 2008, 15